1. Home
  2. PRLD vs CMTL Comparison

PRLD vs CMTL Comparison

Compare PRLD & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • CMTL
  • Stock Information
  • Founded
  • PRLD 2016
  • CMTL 1967
  • Country
  • PRLD United States
  • CMTL United States
  • Employees
  • PRLD N/A
  • CMTL N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PRLD Health Care
  • CMTL Technology
  • Exchange
  • PRLD Nasdaq
  • CMTL Nasdaq
  • Market Cap
  • PRLD 73.7M
  • CMTL 65.9M
  • IPO Year
  • PRLD 2020
  • CMTL N/A
  • Fundamental
  • Price
  • PRLD $0.87
  • CMTL $2.11
  • Analyst Decision
  • PRLD Strong Buy
  • CMTL Strong Buy
  • Analyst Count
  • PRLD 2
  • CMTL 1
  • Target Price
  • PRLD $4.50
  • CMTL $9.25
  • AVG Volume (30 Days)
  • PRLD 200.4K
  • CMTL 371.2K
  • Earning Date
  • PRLD 03-04-2025
  • CMTL 03-17-2025
  • Dividend Yield
  • PRLD N/A
  • CMTL N/A
  • EPS Growth
  • PRLD N/A
  • CMTL N/A
  • EPS
  • PRLD N/A
  • CMTL N/A
  • Revenue
  • PRLD $3,000,000.00
  • CMTL $504,292,000.00
  • Revenue This Year
  • PRLD N/A
  • CMTL N/A
  • Revenue Next Year
  • PRLD N/A
  • CMTL $9.76
  • P/E Ratio
  • PRLD N/A
  • CMTL N/A
  • Revenue Growth
  • PRLD N/A
  • CMTL N/A
  • 52 Week Low
  • PRLD $0.80
  • CMTL $1.53
  • 52 Week High
  • PRLD $6.80
  • CMTL $6.94
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 37.59
  • CMTL 39.75
  • Support Level
  • PRLD $0.87
  • CMTL $2.07
  • Resistance Level
  • PRLD $1.01
  • CMTL $2.52
  • Average True Range (ATR)
  • PRLD 0.08
  • CMTL 0.19
  • MACD
  • PRLD -0.02
  • CMTL 0.05
  • Stochastic Oscillator
  • PRLD 0.90
  • CMTL 31.94

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

Share on Social Networks: